Clinical evaluation of biapenem for febrile neutropenia in patients with hematological disorders

Japanese Journal of Antibiotics

Volumn 60, Issue 2, 2007, Pages 125-131

  Sakai, Hirotaka ^a   Sanada, Masashi ^a   Shimamoto, Kenji ^a   Azuma, Remi ^a   Harada, Hiroshi ^a   Mori, Hiraku ^a   Niikura, Haruo ^a   Omine, Mitsuhiro ^a  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIAPENEM;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; APLASTIC ANEMIA; ARTICLE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEBRILE NEUTROPENIA; FEVER; HEMATOLOGIC DISEASE; HUMAN; INFECTION; LYMPHOMA; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; NEUTROPHIL COUNT; RASH; TREATMENT OUTCOME;

ANEMIA, APLASTIC; CARBAPENEMS; FEVER; HEMATOLOGIC DISEASES; INFUSIONS, INTRAVENOUS; LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, MYELOID; LYMPHOMA; MYELODYSPLASTIC SYNDROMES; NEUTROPENIA; THIENAMYCINS; TREATMENT OUTCOME;

EID: 34250639903     PISSN: 03682781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. YOSHIDA, M.: Infections in patients with hematological diseases: recent advances in serological diagnosis and empiric therapy. Int. J. Hematol. 66: 279-289, 1997
2. PERRY, C. M. & T. IBBOTSON: Biapenem. Drugs 62: 2221-2234, 2002
3. Japanese source
4. Jpn. J. Antibiotics 56: 674-680, 2003
5. Jpn. J. Antibiotics 59: 1-10, 2006
6. HIKIDA, M.; K. KAWASHIMA, M. YOSHIDA, et al.: Inactivation of new carbapenem antibiotics by dehydropeptidase-I from porcine and human renal cortex. J. Antimicrob. Chemother. 30: 129-134, 1992
7. MASAOKA, T.: Evidence-based recommendations for antimicrobial use in febrile neutropenia in Japan: executive summary. Clin. Infect. Dis. 39: S49-52, 2004
8. Japanese source
9. HUGHES, W.T.; D. ARMSTRONG, G.-P. BODEY, et al.: 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin. Infect. Dis. 34: 730-751, 2004
10. Chemotherapy 38: 576-581, 1990
11. TAMURA, K.; J. MATSUOKA, J. TSUKADA, et al.: Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4th-generation cephalosporin + aminoglycosides: comparative study. Am. J. Hematol. 71: 248-255, 2002
12. Japanese source
13. Jpn. J. Antibiotics 47: 35-41, 1999
14. Jpn. J. Antibiotics 45: 687-696, 1992
15. PICAZO, J. J.: Management of the febrile neutropenic patient: a consensus conference. Clin. Infect. Dis. 39: S1-6, 2004
16. Japanese source